Long Ideas

Netflix (NFLX): Next Stop, $460?

Of all the widely followed and top-performing FANG stocks, Netflix (NASDAQ:NFLX) has shot the lights out in terms of share price performance. After …

Momo Inc: A Strong Buy Stock Millennial Investors Can’t Get Enough Of

Is your portfolio ready for “the world’s most important demographic”? This is a question that Bank of America Merrill Lynch has been considering recently.

Are These Two Healthcare Stocks Great Bargains? Analysts Say Yes

By Harriet Lefton You don’t need to spend big to pick up premium stock picks… not when you can use the markets’ current …

Here’s Why You Should Still Own Alibaba (BABA) and Facebook (FB) Stocks

By Harriet Lefton Buckle up — the market is looking jittery right now. If it’s not the threat of further Federal interest rate hikes, …

Galmed Pharmaceuticals (GLMD): Next Stop, $30?

It’s a big day for Galmed Pharmaceuticals (NASDAQ:GLMD). The drug maker released positive phase Phase 2b data for Aramchol in NASH that had many, even …

Square (SQ): Cantor Lights Bigger Fuse on Target Expectations

Cantor’s Joseph Foresi spotlights 16% in return potential now in the wings for SQ stock.

Viking Therapeutics (VKTX) Gains Bigger Vote of Confidence from H.C. Wainwright

Following encouraging NASH data from VKTX’s biotech peer Madrigal, H.C.

Snap: Time to Spook the Bears

Over 17 years, Citron has battled companies with questionable business models, fraudulent practices and companies that are otherwise overvalued. However, staying short a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts